Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum

ISME Journal

Volumn 1, Issue 5, 2007, Pages 403-418

  Baumgart, Martin ^a   Dogan, Belgin ^a   Rishniw, Mark ^a   Weitzman, Gil ^b   Bosworth, Brian ^b   Yantiss, Rhonda ^b   Orsi, Renato H ^c   Wiedmann, Martin ^c   McDonough, Patrick ^a   Kim, Sung Guk ^a   Berg, Douglas ^d   Schukken, Ynte ^a   Scherl, Ellen ^b   Simpson, Kenneth W ^a  

^a Department of Obstetrics Gynecology   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c Plant Breeding and Genetics Section in the School of Integrative Plant Science   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

16S rDNA; Adherent and invasive E. coli; Dysbiosis; Genome subtraction; Inflammatory bowel disease

Indexed keywords

BACTERIAL DNA; RIBOSOME DNA; RNA 16S;

ARTICLE; BACTERIAL GENOME; CHEMISTRY; CLASSIFICATION; CROHN DISEASE; ESCHERICHIA COLI; GENE LIBRARY; GENETICS; GRAM POSITIVE BACTERIUM; HUMAN; ILEUM; INTESTINE MUCOSA; MACROPHAGE; MICROBIOLOGY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYLOGENY; PHYSIOLOGY; TUMOR CELL LINE;

BASE SEQUENCE; CELL LINE, TUMOR; CROHN DISEASE; DNA, BACTERIAL; DNA, RIBOSOMAL; ESCHERICHIA COLI; GENE LIBRARY; GENOME, BACTERIAL; GRAM-POSITIVE BACTERIA; HUMANS; ILEUM; INTESTINAL MUCOSA; MACROPHAGES; MOLECULAR SEQUENCE DATA; PHYLOGENY; RNA, RIBOSOMAL, 16S;

BACTERIA (MICROORGANISMS); CLOSTRIDIALES; ENTEROBACTERIACEAE; ESCHERICHIA COLI; LISTERIA; MYCOBACTERIUM AVIUM; SHIGELLA;

EID: 34548483459     PISSN: 17517362     EISSN: 17517370     Source Type: Journal    
DOI: 10.1038/ismej.2007.52     Document Type: Article

References (57)

1. Ahmad T, Armuzzi A, Bunce M, Mulcahy-Hawes K, Marshall SE, Orchard TR et al. (2002). The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology 122: 854-866.
2. Akopyants NS, Fradkov A, Diatchenko L, Hill JE, Siebert PD, Lukyanov SA et al. (1998). PCR-based subtractive hybridization and differences in gene content among strains of Helicobacter pylori. Proc Natl Acad Sci USA 95: 13108-13113.
3. Arnott ID, Landers CJ, Nimmo EJ, Drummond HE, Smith BK, Targan SR et al. (2004). Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype. Am J Gastroenterol 99: 2376-2384.
4. Barnich N, Darfeuille-Michaud A. (2007). Adherentinvasive Escherichia coli and Crohn's disease. Curr Opin Gastroenterol 23: 16-20.
5. Bartholome AL, Albin DM, Baker DH, Hoist JJ, Tappenden KA. (2004). Supplementation of total parenteral nutrition with butyrate acutely increases structural aspects of intestinal adaptation after an 80% jejunoileal resection in neonatal piglets. JPEN J Parenter Enteral Nutr 28: 210-222; discussion 222-223.
6. Boudeau J, Barnich N, Darfeuille-Michaud A. (2001). Type 1 pili-mediated adherence of Escherichia coli strain LF82 isolated from Crohn's disease is involved in bacterial invasion of intestinal epithelial cells. Mol Microbiol 39: 1272-1284.
7. Boudeau J, Glasser AL, Masseret E, Joly B, Darfeuille-Michaud A. (1999). Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease. Infect Immun 67: 4499-4509.
8. Brzuszkiewicz E, Bruggemann H, Liesegang H, Emmerth M, Olschlager T, Nagy G et al. (2006). How to become a uropathogen: comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains. Proc Natl Acad Sci USA 103: 12879-12884.
9. Clermont O, Bonacorsi S, Bingen E. (2000). Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 66: 4555-4558.
10. Cossart P, Sansonetu PJ. (2004). Bacterial invasion: the paradigms of enteroinvasive pathogens. Science 304: 242-248.
11. Daperno M, D'Haens G, Van Assche G, Baert F, Bulois P, Maunoury V et al. (2004). Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD. Gastrointest Endose 60: 505-512.
12. Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser AL, Barnich N et al. (2004). High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 127: 412-421.
13. DebRoy C, Maddox CW. (2001). Identification of virulence attributes of gastrointestinal Escherichia coli isolates of veterinary significance. Anim Health Res Rev 2: 129-140.
14. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M et al. (2005). Diversity of the human intestinal microbial flora. Science 308: 1635-1638.
15. Elson CO, Cong Y, McCracken VJ, Dimmitt RA, Lorenz RG, Weaver CT. (2005). Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol Rev 206: 260-276.
16. Glasser AL, Boudeau J, Barnich N, Perruchot MH, Colombel JF, Darfeuille-Michaud A. (2001). Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death. Infect Immun 69: 5529-5537.
17. Gophna U, Sommerfeld K, Gophna S, Doolittle WF, Veldhuyzen van Zanten SJ. (2006). Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis. J Clin Microbiol 44: 4136-4141.
18. Hanauer SB. (2006). Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis 12(Suppl 1): S3-S9.
19. Hayashi H, Sakamoto M, Benno Y. (2002). Phylogenetic analysis of the human gut microbiota using 16S rDNA clone libraries and strictly anaerobic culture-based methods. Microbiol Immunol 46: 535-548.
20. Jansen GJ, Mooibroek M, Idema J, Harmsen HJ, Welling GW, Degener JE. (2000). Rapid identification of bacteria in blood cultures by using fluorescently labeled oligonucleotide probes. J Clin Microbiol 38: 814-817.
21. Kim SC, Tonkonogy SL, Albright CA, Tsang J, Balish EJ, Braun J et al. (2005). Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology 128: 891-906.
22. Kim SG, Shin SJ, Jacobson RH, Miller LJ, Harpending PR, Stehman SM et al. (2002). Development and application of quantitative polymerase chain reaction assay based on the ABI 7700 system (TaqMan) for detection and quantification of Mycobacterium avium subsp. paratuberculosis. J Vet Diagn Invest 14: 126-131.
23. Kingsley RA, Humphries AD, Weening EH, De Zoete MR, Winter S, Papaconstantinopoulou A et al. (2003). Molecular and phenotypic analysis of the CS54 island of Salmonella enterica serotype typhimurium: identification of intestinal colonization and persistence determinants. Infect Immun 71: 629-640.
24. Kleessen B, Kroesen AJ, Buhr HJ, Blaut M. (2002). Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scand J Gastroenterol 37: 1034-1041.
25. Kotlowski R, Bernstein CN, Sepehri S, Krause DO. (2007). High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease. Gut 56: 669-675.
26. Lepage P, Seksik P, Sutren M, de la Cochetiere MF, Jian R, Marteau P et al. (2005). Biodiversity of the mucosaassociated microbiota is stable along the distal digestive tract in healthy individuals and patients with IBD. Inflamm Bowel Dis 11: 473-480.
27. Liu Y, van Kruiningen HJ, West AB, Cartun RW, Cortot A, Colombel JF. (1995). Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn's disease. Gastroenterology 108: 1396-1404.
28. Loftus Jr EV. (2004). Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 126: 1504-1517.
29. Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, Frangeul L et al. (2006). Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55: 205-211.
30. Martin HM, Campbell BJ, Hart CA, Mpofu C, Nayar M, Singh R et al. (2004). Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology 127: 80-93.
31. Martinez-Medina M, Aldeguer X, Gonzalez-Huix F, Acero D, Garcia-Gil LJ. (2006). Abnormal microbiota composition in the ileocolonic mucosa of Crohn's disease patients as revealed by polymerase chain reactiondenaturing gradient gel electrophoresis. Inflamm Bowel Dis 12: 1136-1145.
32. Mary JY, Modigliani R. (1989). Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID). Gut 30: 983-989.
33. Masseret E, Boudeau J, Colombel JF, Neut C, Desreumaux P, Joly B et al. (2001). Genetically related Escherichia coli strains associated with Crohn's disease. Gut 48: 320-325.
34. Moulin-Schouleur M, Schouler C, Tailliez P, Kao MR, Bree A, Germon P et al. (2006). Common virulence factors and genetic relationships between 018:K1:H7 Escherichia coli isolates of human and avian origin. J Clin Microbiol 44: 3484-3492.
35. Mylonaki M, Rayment NB, Rampton DS, Hudspith BN, Brostoff J. (2005). Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease. Inflamm Bowel Dis 11: 481-487.
36. Nightingale KK, Lyles K, Ayodele M, Jalan P, Nielsen R, Wiedmann M. (2006). Novel method to identify source-associated phylogenetic clustering shows that Listeria monocytogenes includes niche-adapted clonal groups with distinct ecological preferences. J Clin Microbiolte: 3742-3751.
37. Norton DM, Scarlett JM, Horton K, Sue D, Thimothe J, Boor KJ et al. (2001). Characterization and pathogenic potential of Listeria monocytogenes isolates from the smoked fish industry. Appl Environ Microbiol 67: 646-653.
38. Odze R, Antonioli D, Peppercorn M, Goldman H. (1993). Effect of topical 5-aminosalicylic acid (5-ASA) therapy on rectal mucosal biopsy morphology in chronic ulcerative colitis. Am J Surg Pathol 17: 869-875.
39. Poulsen LK, Lan F, Kristensen CS, Hobolth P, Molin S, Krogfelt KA. (1994). Spatial distribution of Escherichia coli in the mouse large intestine inferred from rRNA in situ hybridization. Infect Immun 62: 5191-5194.
40. Pryde SE, Duncan SH, Hold GL, Stewart CS, Flint HJ. (2002). The microbiology of butyrate formation in the human colon. FEMS Microbiol Lett 217: 133-139.
41. Pukatzki S, Ma AT, Sturtevant D, Krastins B, Sarracino D, Nelson WC et al. (2006). Identification of a conserved bacterial protein secretion system in Vibrio cholerae using the Dictyostelium host model system. Proc Natl Acad Sei USA 103: 1528-1533.
42. Reid SD, Herbelin CJ, Bumbaugh AC, Selander RK, Whittam TS. (2000). Parallel evolution of virulence in pathogenic Escherichia coli. Nature 406: 64-67.
43. Rodriguez-Siek KE, Giddings CW, Doetkott C, Johnson TJ, Fakhr MK, Nolan LK. (2005). Comparison of Escherichia coli isolates implicated in human urinary tract infection and avian colibacillosis. Microbiology 151: 2097-2110.
44. Ryan P, Kelly RG, Lee G, Collins JK, O'Sullivan GC, O'Connell J ef al. (2004). Bacterial DNA within granulomas of patients with Crohn's disease - detection by laser capture microdissection and PCR. Am J Gastroenterol 99: 1539-1543.
45. Sartor RB. (2006). Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 3: 390-407.
46. Schouler C, Koffmann F, Amory C, Leroy-Setrin S, Moulin-Schouleur M. (2004). Genomic subtraction for the identification of putative new virulence factors of an avian pathogenic Escherichia coli strain of 02 serogroup. Microbiology 150: 2973-2984.
47. Seksik P, Lepage P, de la Cochetiere MF, Bourreille A, Sutren M, Galmiche JP et al. (2005). Search for localized dysbiosis in Crohn's disease ulcerations by temporal temperature gradient gel electrophoresis of 16S rRNA. J Clin Microbiol 43: 4654-4658.
48. Shanahan F, O'Mahony J. (2005). The mycobacteria story in Crohn's disease. Am J Gastroenterol 100: 1537-1538.
49. Simpson KW, Dogan B, Rishniw M, Goldstein RE, Klaessig S, McDonough PL et al. (2006). Adherent and invasive Escherichia coli is associated with granulomatous colitis in boxer dogs. Infect Immun 74: 4778-4792.
50. Skyberg JA, Johnson TJ, Johnson JR, Clabots C, Logue CM, Nolan LK. (2006). Acquisition of avian pathogenic Escherichia coli plasmids by a commensal E. coli isolate enhances its abilities to kill chicken embryos, grow in human urine, and colonize the murine kidney. Infect Immun 74: 6287-6292.
51. Sokol H, Seksik P, Rigottier-Gois L, Lay C, Lepage P, Podglajen I et al. (2006). Specificities of the fecal microbiota in inflammatory bowel disease. Inflamm Bowel Dis 12: 106-111.
52. Swidsinski A, Ladhoff A, Pernthaler A, Swidsinski S, Loening-Baucke V, Ortner M et al. (2002). Mucosal flora in inflammatory bowel disease. Gastroenterology 122: 44-54.
53. Swidsinski A, Weber J, Loening-Baucke V, Hale LP, Lochs H. (2005). Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol 43: 3380-3389.
54. Tamboli CP, Neut C, Desreumaux P, Colombel JF. (2004). Dysbiosis in inflammatory bowel disease. Gut 53:1-4.
55. Targan SR, Landers CJ, Yang H, Lodes MJ, Cong Y, Papadakis KA et al. (2005). Antibodies to CBirl flagellin define a unique response that is associated independently with complicated Crohn's disease. Gastroenterology 128: 2020-2028.
56. Wehkamp J, Stange EF. (2006). A new look at Crohn's disease: breakdown of the mucosal antibacterial defense. Ann N Y Acad Sci 1072: 321-331.
57. Welch RA, Burland V, Plunkett III G, Redford P, Roesch P, Rasko D et al. (2002). Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc Natl Acad Sci USA 99: 17020-17024.